LLY stock profile - insider summary
- Name
- Date
- Title
- Total Bought
- Total Sold
- Updated
- IssuerCik
- SubKey
- netTransacted
-
Ricks David A2023/05/10SVP and Pres, Lilly Bio-Meds170728-408462023-05-1000000594780000059478129882
-
Hedley Mary Lynne2023/05/09512023-05-090000059478000005947851
-
Hedley Mary Lynne2023/05/08512023-05-080000059478000005947851
-
Hedley Mary Lynne2023/05/07512023-05-070000059478000005947851
-
Hedley Mary Lynne2023/05/06512023-05-060000059478000005947851
-
LECHLEITER JOHN C2023/05/05President and COO155390-766662023-05-050000059478000005947878724
-
Hedley Mary Lynne2023/05/04512023-05-040000059478000005947851
-
Ricks David A2023/05/03SVP and Pres, Lilly Bio-Meds170728-408462023-05-0300000594780000059478129882
-
Skovronsky Daniel2023/05/02SVP, CSO, and Pres. LRL1105572023-05-0200000594780000059478110557
-
Ricks David A2023/05/01SVP and Pres, Lilly Bio-Meds170728-408462023-05-0100000594780000059478129882
Related News

BlackRock (NYSE:BLK) Stock: A Resilient Investment at $747.91 With Promising Growth Ahead
TradingNEWS Archive
11.05.25

Can NASDAQ:BIDU Surge Above $200? How Will AI and Robotaxi Businesses Impact Baidu’s Future Price?
TradingNEWS Archive
10.05.25

Is NASDAQ: INTC Ready for a Strong Recovery in 2025?
TradingNEWS Archive
10.05.25

Shell’s Bold Move: Can a Potential BP Acquisition Propel NYSE:SHEL to New Heights Amid $60 Brent Prices?
TradingNEWS Archive
09.05.25